A unique technology to rapidly screen new drugs, therapies

drug
Credit: CC0 Public Domain

The University of Colorado Anschutz Medical Campus announced a new robotic screening and imaging technology today marking a major breakthrough in the detection and treatment of disease.

The technology, made possible by a gift to the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, could cut the screening time for new drug therapies by half. That means therapies and pharmaceuticals could be ready for patients faster than ever before.

“This technology does not exist at any academic institution in the Mountain West and is limited between the two coasts, placing the CU Anschutz Medical Campus in a unique position to advance drug discovery in Colorado and beyond,” said David Ross, Ph.D., associate dean for research at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences. “We envision this new screening and imaging technology will be applied to both small molecule and biologic drug development

Read More

CU Anschutz announces unique technology to rapidly screen new drugs, therapies

The University of Colorado Anschutz Medical Campus announced a new robotic screening and imaging technology today marking a major breakthrough in the detection and treatment of disease.

The technology, made possible by a gift to the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, could cut the screening time for new drug therapies by half. That means therapies and pharmaceuticals could be ready for patients faster than ever before.

“This technology does not exist at any academic institution in the Mountain West and is limited between the two coasts, placing the CU Anschutz Medical Campus in a unique position to advance drug discovery in Colorado and beyond,” said David Ross, PhD, associate dean for research at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences. “We envision this new screening and imaging technology will be applied to both small molecule and biologic drug development and will position the

Read More

Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using its DehydraTECH technology in Delivering Antiviral Drugs

(TheNewswire)

Company Raises Commitment to Antiviral Research with Launch of Rodent Antiviral Drug Delivery Study with Potential COVID-19 Applications

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today provides an update on a previously announced antiviral research initiative and introduces a new research project with potential COVID-19 applications

On March 19 2020, Lexaria announced that it planned to conduct a pilot human pharmacokinetic exploratory study in healthy volunteers of antiviral drugs that have previously been studied against other coronavirus strains, comparing Lexaria’s DehydraTECH TM formulations to controls without Lexaria’s technology.

The ethics board approval required as a first step in this pilot study has now been received, conditional on further government regulatory approval also being granted. Lexaria will now begin the process of pursuing the necessary steps to file for approval from federal regulators.

In parallel with this, Lexaria is also announcing

Read More

A Bet on Europe Is a Bet on Drugs, Against Tech

The skew toward tech giants in the U.S. stock market is well known. Less appreciated is that Europe’s markets are now dominated by drugmakers.

Healthcare accounts for a quarter of the Stoxx Europe 50 index—almost as much as the almost 28% represented by information technology in the S&P 500. Five of Europe’s top 10 companies by market value are now drug producers:

Novartis,

Roche,

AstraZeneca,

Sanofi

and Denmark’s

Novo Nordisk.

This trend isn’t new, but it has been turbocharged by this year’s pandemic-driven downturn, which has highlighted the social relevance of the drug industry as well as its typically recession-proof profit profile. A vaccine AstraZeneca has licensed from the University of Oxford is a front-runner in the battle against Covid-19.

The rise of health care is one result to emerge from an analysis of Europe’s largest companies and how they have shifted over the past decade and

Read More

Global Ovarian Cancer Treatment Drugs Market 2020 Sales Channels, Technology and Production Analysis, Business Growth by 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 23, 2020 (CDN Newswire via Comtex) —
Global Ovarian Cancer Treatment Drugs Market 2020 by Manufacturers, Type and Application, Forecast to 2025 aimed at strengthening players’ overall growth and offering a strong position in their business, explores facts, events, and possible variations in the market considering regional and global levels. The report contains detailed, accurate research studies that provide an in-depth analysis of global Ovarian Cancer Treatment Drugs market dynamics. The report highlights significant insights about the market involving market size, application, fundamental statistics, market share, and growth factors. The research incorporates an exact competitive assessment of industry players and their valuable strategies during the projected timeframe 2020 to 2025.

The report profoundly evaluated in the report covering scope, profitability, demand status, uncertainties, and development forecast. Then report compiles in-depth analysis on critical subjects of the

Read More

Influenza Drugs Market 2020 Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 24, 2020 (The Expresswire) —
Global “”Influenza Drugs Market“”(2020-2026) status and position of worldwide and key regions, with perspectives of manufacturers, regions, product types and end industries; this report analyses the topmost companies in worldwide and main regions, and splits the Influenza Drugs market by product type and applications/end industries.The Influenza Drugs market trend research process includes the analysis of different factors affecting the industry, with the government policy, competitive landscape, historical data, market environment, present trends in the market, upcoming technologies,technological innovation, and the technical progress in related industry, and market risks, market barriers,opportunities, and challenges.

Get a sample PDF of the report at-https://www.360researchreports.com/enquiry/request-sample/16172948

The global Influenza Drugs market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at

Read More

Anticancer Drugs Market 2020 Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 21, 2020 (The Expresswire) —
Global “Anticancer Drugs Market” (2020-2026) status and position of worldwide and key regions, with perspectives of manufacturers, regions, product types and end industries; this report analyses the topmost companies in worldwide and main regions, and splits the Anticancer Drugs market by product type and applications/end industries.The Anticancer Drugs market trend research process includes the analysis of different factors affecting the industry, with the government policy, competitive landscape, historical data, market environment, present trends in the market, upcoming technologies,technological innovation, and the technical progress in related industry, and market risks, market barriers,opportunities, and challenges.

Get a sample PDF of the report at-https://www.360researchreports.com/enquiry/request-sample/15423367

The global Anticancer Drugs market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing

Read More